Needlestick injury prevention – puncturing the myths

Issues relating to people with diabetes injecting themselves with insulin quite rightly are an important focus of diabetes care. Concerns include avoiding the complications of inaccurate dosing, and ensuring the proper care of injection sites and correct use of blood glucose selfmonitoring. The current implementation of the 2010 EU Directive on sharps injury prevention, places the spotlight of attention on the safety and protection of healthcare professionals when they are administering treatment to people with diabetes. Questions arise over the risks to the diabetes specialist. Apparently, false assumptions abound regarding the risk of needlestick injuries and infection in diabetes treatment that need to be addressed. This short article reviews some commonly held misconceptions and provides evidence on which the authors refute them.


Attachment: 
Section: